AU2019205134B9 - Minocycline for treating inflammatory skin conditions - Google Patents

Minocycline for treating inflammatory skin conditions Download PDF

Info

Publication number
AU2019205134B9
AU2019205134B9 AU2019205134A AU2019205134A AU2019205134B9 AU 2019205134 B9 AU2019205134 B9 AU 2019205134B9 AU 2019205134 A AU2019205134 A AU 2019205134A AU 2019205134 A AU2019205134 A AU 2019205134A AU 2019205134 B9 AU2019205134 B9 AU 2019205134B9
Authority
AU
Australia
Prior art keywords
minocycline
pharmaceutical composition
rosacea
composition
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019205134A
Other languages
English (en)
Other versions
AU2019205134A1 (en
AU2019205134B2 (en
AU2019205134A2 (en
Inventor
Shavas ALIKUNJU
Anirudh GAUTAM
Swati Kulkarni
Bijay Kumar Padhi
Rajeev Singh Raghuvanshi
Srinivas Ramchandra SIDGIDDI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Journey Medical Corp
Original Assignee
Journey Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65269058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2019205134(B9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Journey Medical Corp filed Critical Journey Medical Corp
Publication of AU2019205134A1 publication Critical patent/AU2019205134A1/en
Publication of AU2019205134A2 publication Critical patent/AU2019205134A2/en
Publication of AU2019205134B2 publication Critical patent/AU2019205134B2/en
Priority to AU2025200826A priority Critical patent/AU2025200826A1/en
Application granted granted Critical
Publication of AU2019205134B9 publication Critical patent/AU2019205134B9/en
Assigned to JOURNEY MEDICAL CORPORATION reassignment JOURNEY MEDICAL CORPORATION Request for Assignment Assignors: DR. REDDY'S LABORATORIES LTD.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2019205134A 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions Active AU2019205134B9 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025200826A AU2025200826A1 (en) 2018-01-07 2025-02-06 Minocycline for treating inflammatory skin conditions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201741023993 2018-01-07
IN201741023993 2018-01-07
PCT/IB2019/000144 WO2019135166A1 (en) 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025200826A Division AU2025200826A1 (en) 2018-01-07 2025-02-06 Minocycline for treating inflammatory skin conditions

Publications (4)

Publication Number Publication Date
AU2019205134A1 AU2019205134A1 (en) 2020-08-20
AU2019205134A2 AU2019205134A2 (en) 2020-08-20
AU2019205134B2 AU2019205134B2 (en) 2024-11-07
AU2019205134B9 true AU2019205134B9 (en) 2025-02-20

Family

ID=65269058

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019205134A Active AU2019205134B9 (en) 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions
AU2025200826A Pending AU2025200826A1 (en) 2018-01-07 2025-02-06 Minocycline for treating inflammatory skin conditions

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025200826A Pending AU2025200826A1 (en) 2018-01-07 2025-02-06 Minocycline for treating inflammatory skin conditions

Country Status (11)

Country Link
US (4) US11191740B2 (https=)
EP (1) EP3735249A1 (https=)
JP (3) JP7561029B2 (https=)
KR (1) KR102705507B1 (https=)
CN (1) CN111818927A (https=)
AU (2) AU2019205134B9 (https=)
BR (1) BR112020013789A2 (https=)
CA (1) CA3087838A1 (https=)
EA (1) EA202091653A1 (https=)
MX (1) MX2020007222A (https=)
WO (1) WO2019135166A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン
CA3106884C (en) * 2018-07-19 2025-04-01 Doosan Bobcat North America, Inc. DISPLAY POSITION FOR CABIN WITH TILTING DOOR
CN120324439A (zh) * 2025-03-05 2025-07-18 福安药业集团宁波天衡制药有限公司 一种稳定的盐酸米诺环素胶囊及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2221056A1 (en) * 2001-04-05 2010-08-25 Collagenex Pharmaceuticals, Inc. Tetracyclines for the treatment of acne
US20120093892A1 (en) * 2005-06-24 2012-04-19 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20140186269A1 (en) 2013-01-03 2014-07-03 Foamix Ltd. Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2221056A1 (en) * 2001-04-05 2010-08-25 Collagenex Pharmaceuticals, Inc. Tetracyclines for the treatment of acne
US20120093892A1 (en) * 2005-06-24 2012-04-19 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LEYDEN JAMES J et al., "Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report", DERMATOL CLIN, 2009, vol. 27, no. 1, pages 1 - 15, DOI: 10.1016/J.DET.2008.07.008 *

Also Published As

Publication number Publication date
EA202091653A1 (ru) 2020-12-23
CA3087838A1 (en) 2019-07-11
KR102705507B1 (ko) 2024-09-10
WO2019135166A9 (en) 2020-07-16
AU2019205134A1 (en) 2020-08-20
US10905664B2 (en) 2021-02-02
AU2019205134B2 (en) 2024-11-07
RU2020125984A3 (https=) 2022-02-07
US12594252B2 (en) 2026-04-07
KR20200108018A (ko) 2020-09-16
BR112020013789A2 (pt) 2021-02-17
JP2026031656A (ja) 2026-02-24
JP2021509409A (ja) 2021-03-25
US20200222345A1 (en) 2020-07-16
RU2020125984A (ru) 2022-02-07
AU2019205134A2 (en) 2020-08-20
EP3735249A1 (en) 2020-11-11
US11191740B2 (en) 2021-12-07
JP7561029B2 (ja) 2024-10-03
JP2024098011A (ja) 2024-07-19
US20190209500A1 (en) 2019-07-11
WO2019135166A1 (en) 2019-07-11
CN111818927A (zh) 2020-10-23
US20210121420A1 (en) 2021-04-29
MX2020007222A (es) 2020-12-10
US11364212B2 (en) 2022-06-21
AU2025200826A1 (en) 2025-02-27
US20230131030A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
US12594252B2 (en) Methods for treating inflammatory skin conditions
WO2018108152A1 (zh) 一种奥拉帕尼口服缓控释药物组合物及其用途
KR20240162560A (ko) 에플로르니틴 및 설린닥, 고정된 용량 조합 제제
US20240424003A1 (en) Pharmaceutical compositions for minocycline
US20220031714A1 (en) Modified release doxycycline composition
RU2787528C2 (ru) Миноциклин для лечения воспалительных заболеваний кожи
EA045615B1 (ru) Миноциклин для лечения воспалительных заболеваний кожи
HK40039196A (en) Minocycline for treating inflammatory skin conditions
WO2011128914A2 (en) Extended release pharmaceutical compositions of pramipexole
TWI743059B (zh) 二氟甲基鳥氨酸及舒林酸（ｓｕｌｉｎｄａｃ），固定劑量組合調配物

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 31 JUL 2020

SREP Specification republished
PC1 Assignment before grant (sect. 113)

Owner name: JOURNEY MEDICAL CORPORATION

Free format text: FORMER APPLICANT(S): DR. REDDY'S LABORATORIES LTD.

FGA Letters patent sealed or granted (standard patent)